Skip to main content

Adma Biologics, Inc.

ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001368514

No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.72B in total; superinvestors Duquesne Family Office and Fundsmith hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Adma Biologics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Adma Biologics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Adma Biologics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Kestenberg-Messina Kaitlin M.COO and SVP, Compliance443,061Jul 28, 20265
Kohler TerryCFO and Treasurer143,149Jul 17, 20261
Grossman Jerrold BDirector520,284May 28, 20264
Grossman Adam SPresident and CEO2,112,777Mar 17, 20269
Guiheen Lawrence P.Director30,000IndirectMar 17, 20262
Elms SteveDirector2,045,730IndirectMar 9, 20262
Tade Brad L.CFO and Treasurer232,940Feb 23, 20261
Finger Alison CecilyDirector45,619Feb 11, 20261
Kwon YoungDirector263,020Feb 11, 20261
Salas Eduardo ReneDirector21,579Feb 11, 20261
Lenz BrianEVP, CFO703,002Mar 8, 20240
Fong BryantDirector83,941Feb 28, 20240
Demski Martha JDirector56,601IndirectMar 8, 20230
Edelman Joseph10% Owner13,262,375IndirectSep 30, 20210
Perceptive Advisors LLC10% Owner13,262,375IndirectSep 30, 20210
Perceptive Life Sciences Master Fund Ltd10% Owner13,262,375IndirectSep 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 28, 2026 (view filing)May 271 dayGrossman Jerrold BDirectorPPurchase+6.40K$7.91+$50.6K+1.2%520.3K after
May 14, 2026 (view filing)May 122 daysGrossman Jerrold BDirectorPPurchase+12.5K$8.01+$100.1K+2.5%513.9K after
May 12, 2026 (view filing)May 111 dayGrossman Jerrold BDirectorPPurchase+12.5K$8.01+$100.1K+2.6%501.4K after
Mar 17, 2026 (view filing)Mar 161 dayGrossman Adam SPresident and CEOSSale−21.0K$15.16−$318.4K−1.0%2.11M after2 lots10b5-1
Mar 10, 2026 (view filing)Mar 91 dayKestenberg-Messina Kaitlin M.COO and SVP, ComplianceSSale−10.1K$15.63−$157.8K−2.1%466.6K after
Mar 9, 2026 (view filing)Mar 5-64 daysElms SteveDirectorPPurchase+14.0K$15.53+$217.4K+0.7%2.05M after2 lots
Feb 17, 2026 (view filing)Feb 17Same dayGrossman Adam SPresident and CEOSSale−21.0K$16.08−$337.7K−0.9%2.28M after2 lots10b5-1
Dec 16, 2025 (view filing)Dec 151 dayGrossman Adam SPresident and CEOSSale−21.0K$19.79−$415.6K−1.0%2.01M after2 lots10b5-1
Nov 21, 2025 (view filing)Nov 192 daysGrossman Adam SPresident and CEOSSale−21.0K$16.00−$336.0K−1.0%2.01M after2 lots10b5-1
Oct 24, 2025 (view filing)Oct 24Same dayGrossman Adam SPresident and CEOSSale−21.0K$16.00−$336.0K−1.0%2.02M after2 lots10b5-1
Sep 16, 2025 (view filing)Sep 151 dayGrossman Adam SPresident and CEOSSale−21.0K$16.13−$338.7K−1.0%2.03M after2 lots10b5-1
Aug 15, 2025 (view filing)Aug 15Same dayGrossman Adam SPresident and CEOSSale−21.0K$16.88−$354.5K−1.0%2.03M after2 lots10b5-1
Jul 16, 2025 (view filing)Jul 151 dayGrossman Adam SPresident and CEOSSale−21.0K$18.66−$391.9K−1.0%2.04M after2 lots10b5-1
Jun 18, 2025 (view filing)Jun 162 daysGrossman Adam SPresident and CEOSSale−21.0K$20.81−$437.0K−1.0%2.04M after2 lots10b5-1
Jun 16, 2025 (view filing)Jun 124 daysElms SteveDirectorSSale−92.9K$21.69−$2.02M−4.4%2.03M after
Jun 16, 2025 (view filing)Jun 13-163 daysElms SteveDirectorSSale−332.7K$20.48−$6.81M−79.2%87.3K after2 lots
Jun 11, 2025 (view filing)Jun 92 daysGuiheen Lawrence P.DirectorSSale−20.0K$20.96−$419.2K−17.4%94.8K after
Jun 10, 2025 (view filing)Jun 91 dayGrossman Jerrold BDirectorSSale−10.0K$21.31−$213.1K−2.0%478.2K after
May 23, 2025 (view filing)May 21-222 daysGuiheen Lawrence P.DirectorSSale−9.00K$20.29−$182.6K−7.3%114.8K after2 lots
May 16, 2025 (view filing)May 151 dayGrossman Adam SPresident and CEOSSale−21.0K$19.45−$408.4K−1.0%2.05M after2 lots10b5-1
Apr 16, 2025 (view filing)Apr 151 dayGrossman Adam SPresident and CEOSSale−21.0K$21.46−$450.7K−1.0%2.06M after2 lots10b5-1
Mar 21, 2025 (view filing)Mar 192 daysGrossman Adam SPresident and CEOSSale−21.0K$18.92−$397.3K−1.0%2.06M after2 lots10b5-1
Nov 22, 2024 (view filing)Nov 22Same dayTade Brad L.CFO and TreasurerSSale−15.0K$21.15−$317.3K−7.0%199.4K after
Nov 22, 2024 (view filing)Nov 22Same dayGrossman Adam SPresident and CEOSSale−49.0K$21.10−$1.03M−2.4%1.99M after
Sep 11, 2024 (view filing)Sep 92 daysGuiheen Lawrence P.DirectorSSale−9.00K$18.47−$166.2K−5.5%153.9K after
Aug 30, 2024 (view filing)Aug 30Same dayKestenberg-Messina Kaitlin M.COO and SVP, ComplianceSSale−24.1K$16.90−$408.1K−5.1%449.1K after
Aug 30, 2024 (view filing)Aug 291 dayGrossman Jerrold BDirectorSSale−136.9K$17.27−$2.36M−22.7%467.3K after
Aug 27, 2024 (view filing)Aug 26-271 dayGrossman Adam SPresident and CEOSSale−626.2K$17.44−$10.9M−23.3%2.06M after2 lots
Aug 27, 2024 (view filing)Aug 234 daysKwon YoungDirectorSSale−60.0K$18.26−$1.10M−19.9%241.4K after
Jun 14, 2024 (view filing)Jun 14Same dayGrossman Adam SPresident,CEO, and Interim CFOSSale−100.0K$10.72−$1.07M−4.6%2.08M after
Mar 19, 2024 (view filing)Mar 18-191 dayElms SteveDirectorSSale−461.7K$6.07−$2.80M−17.9%2.12M after2 lots
Mar 15, 2024 (view filing)Mar 13-152 daysElms SteveDirectorSSale−1.04M$6.11−$6.34M−28.7%2.58M after3 lots
Aug 30, 2023 (view filing)Aug 30Same dayGrossman Jerrold BDirectorPPurchase+130.0K$3.71+$482.3K+41.5%443.3K after
Aug 24, 2023 (view filing)Aug 24Same dayKwon YoungDirectorPPurchase+25.0K$3.90+$97.5K+9.9%277.4K after
Aug 23, 2023 (view filing)Aug 221 dayFong BryantDirectorSSale−1.43M$3.87−$5.55M−100.0%0 after
Aug 18, 2023 (view filing)Aug 18Same dayGrossman Adam SPresident and CEOSSale−250.0K$4.15−$1.04M−9.9%2.27M after
Aug 17, 2023 (view filing)Aug 15-162 daysGrossman Adam SPresident and CEOSSale−510.5K$4.54−$2.32M−16.8%2.52M after2 lots
Aug 17, 2023 (view filing)Aug 15-162 daysLenz BrianEVP, CFOSSale−389.8K$4.53−$1.77M−33.3%782.0K after2 lots
Dec 9, 2022 (view filing)Dec 9Same dayLenz BrianEVP, CFOPPurchase+6.99K$2.86+$20.0K+0.7%1.03M after
Dec 9, 2022 (view filing)Dec 9Same dayGrossman Adam SPresident and CEOPPurchase+15.0K$2.86+$42.9K+0.7%2.20M after
Dec 9, 2022 (view filing)Dec 9Same dayGrossman Adam SPresident and CEOPPurchase+15.0K$2.86+$42.8K+1.3%1.14M after
Oct 26, 2021 (view filing)Oct 251 dayKwon YoungDirectorPPurchase+100.0K$1.00+$100.0K+100.0%200.0K after
Oct 26, 2021 (view filing)Oct 251 dayGrossman Jerrold BDirectorPPurchase+100.0K$1.00+$100.0K+62.2%260.9K after
Oct 26, 2021 (view filing)Oct 251 dayLenz BrianEVP, CFOPPurchase+30.0K$1.00+$30.0K+2.9%1.07M after
Oct 26, 2021 (view filing)Oct 251 dayGrossman Adam SPresident and CEOPPurchase+100.0K$1.00+$100.0K+4.9%2.14M after
Oct 26, 2021 (view filing)Oct 251 dayGrossman Adam SPresident and CEOPPurchase+250.0K$1.00+$250.0K+28.5%1.13M after
Sep 30, 2021 (view filing)7:27 PM ETSep 28-302 daysEdelman Joseph and 2 others10% OwnerSSale−260.6K$1.15−$299.2K−1.9%13.3M after3 lots
Sep 29, 2021 (view filing)7:18 PM ETSep 24-275 daysLateEdelman Joseph and 2 others10% OwnerSSale−500.0K$1.25−$622.5K−3.6%13.5M after2 lots
Sep 28, 2021 (view filing)4:18 PM ETSep 235 daysLateEdelman Joseph and 2 others10% OwnerSSale−780.0K$1.27−$990.6K−5.3%14.0M after
Aug 19, 2021 (view filing)7:58 PM ETAug 17-192 daysEdelman Joseph and 2 others10% OwnerSSale−1.78M$1.31−$2.33M−10.7%14.8M after3 lots